Maturing Mycobacterium smegmatis peptidoglycan requires non-canonical crosslinks to maintain shape

Author:

Baranowski Catherine1ORCID,Welsh Michael A2ORCID,Sham Lok-To23,Eskandarian Haig A45ORCID,Lim Hoong Chuin2,Kieser Karen J1,Wagner Jeffrey C1,McKinney John D4,Fantner Georg E5,Ioerger Thomas R6,Walker Suzanne2,Bernhardt Thomas G2ORCID,Rubin Eric J12ORCID,Rego E Hesper7ORCID

Affiliation:

1. Department of Immunology and Infectious Disease, Harvard TH Chan School of Public Health, Boston, United States

2. Department of Microbiology and Immunobiology, Harvard Medical School, Boston, United States

3. Department of Microbiology and Immunology, National University of Singapore, Singapore, Singapore

4. School of Life Sciences, Swiss Federal Institute of Technology in Lausanne, Lausanne, Switzerland

5. School of Engineering, Swiss Federal Institute of Technology in Lausanne, Lausanne, Switzerland

6. Department of Computer Science and Engineering, Texas A&M University, Texas, United States

7. Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, United States

Abstract

In most well-studied rod-shaped bacteria, peptidoglycan is primarily crosslinked by penicillin-binding proteins (PBPs). However, in mycobacteria, crosslinks formed by L,D-transpeptidases (LDTs) are highly abundant. To elucidate the role of these unusual crosslinks, we characterized Mycobacterium smegmatis cells lacking all LDTs. We find that crosslinks generate by LDTs are required for rod shape maintenance specifically at sites of aging cell wall, a byproduct of polar elongation. Asymmetric polar growth leads to a non-uniform distribution of these two types of crosslinks in a single cell. Consequently, in the absence of LDT-mediated crosslinks, PBP-catalyzed crosslinks become more important. Because of this, Mycobacterium tuberculosis (Mtb) is more rapidly killed using a combination of drugs capable of PBP- and LDT- inhibition. Thus, knowledge about the spatial and genetic relationship between drug targets can be exploited to more effectively treat this pathogen.

Funder

National Institutes of Health

Burroughs Wellcome Fund

American Heart Association

Simons Foundation

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Seventh Framework Programme

European Molecular Biology Organization

National Science Foundation

Innovative Medicines Initiative

EU-FP7/Eurostars

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3